Annexon, Inc. Price & Performance (ANNX)

Annexon, Inc. has granted a stock option to a new non-executive employee under its 2022 Employment Inducement Award Plan. The award, approved on April 11, 2025, allows for the purchase of 105,000 shares at $1.54 per share, vesting over four years. This move aims to attract and retain talent.12

Annexon stock rose 2.10% on April 17, closing at $1.46, but remains in a declining trend, down 20% over the last ten days. Technical analysis signals continued high volatility and risk, with the stock expected to fall further in the next three months unless current conditions shift.3

Annexon shares hit a 52-week low of $2.28 in late March, reflecting a 70% annual decline. Despite market challenges, analysts maintain bullish long-term targets, recently adjusting price forecasts to $20. The outlook hinges on upcoming trial results for ANX1502 and progress in the Guillain-Barré Syndrome program.4